Wordt geladen...
Prior Treatment Time Affects Survival Outcomes in Metastatic Breast Cancer
PURPOSE: Sequential drug treatments in metastatic breast cancer (MBC) are disparate. Clinical trial data includes limited reporting of treatment context, primarily including the number of prior therapies. This study evaluates the relationship between prior treatment time, prior lines of treatment, a...
Bewaard in:
| Gepubliceerd in: | JCO Clin Cancer Inform |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Clinical Oncology
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444642/ https://ncbi.nlm.nih.gov/pubmed/32479187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.20.00008 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|